Quantcast

Latest biopharmaceutical Stories

2014-10-20 08:32:21

Expands rHuPH20 Production SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has approved new contract manufacturing facilities used in the production of Hylenex(®) recombinant (hyaluronidase human injection). The FDA approved the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in Hylenex, and the...

2014-10-20 08:27:27

NEW YORK, Oct. 20, 2014 /PRNewswire/ -- Mapp Biopharmaceutical's valiant effort to produce more of their experimental ZMapp(TM) antibody therapeutic to fight the Ebola outbreak will make the public aware of how difficult and time-consuming the production of pharmaceuticals can be, according to Kalorama Information. The healthcare market research publisher said that while some may be taken aback by the three-month production cycle of this compound, those with industry knowledge are...

2014-10-14 23:09:20

Selexis has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development for Europe. Geneva, Switzerland (PRWEB) October 14, 2014 Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development, has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development. Bocci...

2014-10-07 08:30:26

IDT Biologika is among the few biopharmaceutical CMOs in Europe to offer a unique combination of sterile liquid dosage forms and vaccines contract manufacturing services LONDON, Oct. 7, 2014 /PRNewswire/ -- Based on its recent analysis of the biopharmaceutical contract manufacturing industry, Frost & Sullivan recognizes IDT Biologika with the 2014 Europe Frost & Sullivan Award for Customer Service Leadership. IDT Biologika's high-quality customer care, best-in-class practices, and...

2014-10-06 12:25:17

NEW YORK, Oct. 6, 2014 /PRNewswire/ -- The FDA's grant of permission of "expanded access" to Tekmira to administer an experimental medicine for Ebola highlights not only the grave threat the disease outbreak presents, but also the difficulty of bringing life-saving products such as vaccines to market, according to Kalorama Information. The healthcare market research publisher studied vaccine production in its recent report, Biopharmaceutical and Vaccine Production Markets....

2014-10-03 23:07:20

Learn how SAS Grid improves services to SAS users, improves performance and administration for IT, and why it is being adopted at biopharmaceutical companies and CROs worldwide. (PRWEB) October 03, 2014 d-Wise announced today that it will host an educational webinar on October 7th about modernizing legacy SAS clinical trials environments using SAS Grid Manager. Too many biopharmaceutical companies and contract research organizations (CRO’s) with legacy SAS environments are struggling to...

2014-10-03 16:24:22

SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that China Oncology Focus Limited, an Affiliate of Lee's Pharmaceutical Holdings Limited (Lee's Pharma), a public biopharmaceutical company listed on the main board of Hong Kong Stock Exchange (0950) with over 20 years of operation in China's pharmaceutical industry, has...

2014-10-03 08:24:22

SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for PEGylated recombinant human hyaluronidase (PEGPH20) for the treatment of pancreatic cancer. The FDA Office of Orphan Products Development (OOPD) mission is to advance the evaluation and development of products (drugs, biologics, devices, or medical foods) that demonstrate promise for the diagnosis...

2014-10-02 23:01:58

Finalists are announced for eight awards covering collaborations, business strategies, and social corporate responsibility and upstream, downstream and analytical technology applications. The awards recognize outstanding achievements made by individuals, teams, partners and innovative collaborators within the bioprocessing industry. New York, NY (PRWEB) October 02, 2014 BioProcess International (BPI), a business-to-business publication, today announced the finalists for the 2014...

2014-10-01 08:30:24

-- Primary endpoint was met for 50 mg twice daily dosing -- FREMONT, Calif., Oct. 1, 2014 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C). Results from this study demonstrated statistically significant and...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related